BIA
CRDF icon

Biondo Investment Advisors’s Cardiff Oncology CRDF Stock Holding History

Biondo Investment Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-417
Closed -$215K – 98
2013
Q3 		$215K Buy
+417
New +$237K 0.08% 90

Other funds holding CRDF

BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Biondo Investment Advisors's CRDF Position: Q4 2013 in Review

Biondo Investment Advisors sold out of Cardiff Oncology (CRDF) in Q4 2013, closing a stake of 417 shares — an estimated $215K sold.

Biondo Investment Advisors first reported a position in CRDF in Q3 2013 and held it in 1 quarter. The position peaked at $215K in Q3 2013. 26 funds tracked by Wall St. Rank hold CRDF as of Q4 2013.

  • Biondo Investment Advisors reported no remaining Cardiff Oncology position as of Q4 2013 after selling out during the quarter.
  • Biondo Investment Advisors sold 417 Cardiff Oncology shares in Q4 2013, an estimated $215K.
  • Biondo Investment Advisors first reported a position in Cardiff Oncology in Q3 2013 and held it in 1 quarter.
  • Biondo Investment Advisors's Cardiff Oncology position peaked at $215K in Q3 2013.
  • 26 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2013.

Based on Biondo Investment Advisors's 13F filing for Q4 2013, filed 9 Jan 2014.